p53 Mutations and loss of p53 function confer multidrug resistance in neuroblastoma

Medical and Pediatric Oncology

Volumn 35, Issue 6, 2000, Pages 563-568

  Keshelava, Nino ^a,b   Zuo, Juan Juan ^a,b   Sitara Waidyaratne, N ^a,b   Triche, Timothy J ^a,b   Patrick Reynolds, C ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer chemotherapy; Drug resistance; Mutation; Neuroblastoma

Indexed keywords

CARBOPLATIN; ETOPOSIDE; MELPHALAN; PROTEIN P53;

CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DRUG SENSITIVITY; GENE FUNCTION; GENE LOSS; GENE MUTATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NEUROBLASTOMA; PRIORITY JOURNAL;

CHROMOSOME DELETION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG RESISTANCE, NEOPLASM; GENES, P53; HUMANS; MUTATION; NEOPLASM PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED;

EID: 0033646912     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J     Document Type: Conference Paper

References (27)

1. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis- retinoic acid. Children's cancer group
2. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
3. p53: Puzzle and paradigm
4. Twenty years of p53 research: Structural and functional aspects of the p53 protein
5. p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin
6. Chemotherapy-induced apoptosis in melanoma cells is p53 dependent
7. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line
8. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer
9. Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: Spontaneously mutant selection
10. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
11. Low frequency of the p53 gene mutations in neuroblastoma
12. Mutation of the p53 gene in neuroblastoma and its relationship with N- myc amplification
13. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines
14. Concomitant p53 mutation and MYCN amplification in neuroblastoma
15. Absence of p53 gene mutations in primary neuroblastomas
16. No TP53 mutations in neuroblastomas detected by PCR-SSCP analysis
17. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas
18. Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide
19. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization
20. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated
21. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines [see comments]
22. p53 status and the efficacy of cancer therapy in vivo
23. Modulation of transcriptional regulatory properties of p53 by HPV E6
24. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
25. Synergism of BSO and melphalan against neuroblastoma cell lines derived after disease progression
26. Immunotherapy of neuroblastoma
27. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines